These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25768729)

  • 1. Elucidating the Role of Site-Specific Nitration of α-Synuclein in the Pathogenesis of Parkinson's Disease via Protein Semisynthesis and Mutagenesis.
    Burai R; Ait-Bouziad N; Chiki A; Lashuel HA
    J Am Chem Soc; 2015 Apr; 137(15):5041-52. PubMed ID: 25768729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the role of 3-nitrotyrosine residues in the formation of alpha-synuclein oligomers and fibrils.
    Chavarría C; Ivagnes R; Zeida A; Piñeyro MD; Souza JM
    Arch Biochem Biophys; 2024 Feb; 752():109858. PubMed ID: 38104957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.
    Chen H; Zhao YF; Chen YX; Li YM
    ACS Chem Neurosci; 2019 Feb; 10(2):910-921. PubMed ID: 30628768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semisynthesis and Enzymatic Preparation of Post-translationally Modified α-Synuclein.
    Fauvet B; Lashuel HA
    Methods Mol Biol; 2016; 1345():3-20. PubMed ID: 26453202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
    Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
    J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation.
    Hodara R; Norris EH; Giasson BI; Mishizen-Eberz AJ; Lynch DR; Lee VM; Ischiropoulos H
    J Biol Chem; 2004 Nov; 279(46):47746-53. PubMed ID: 15364911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F alpha-synuclein.
    Kaylor J; Bodner N; Edridge S; Yamin G; Hong DP; Fink AL
    J Mol Biol; 2005 Oct; 353(2):357-72. PubMed ID: 16171820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.
    Benner EJ; Banerjee R; Reynolds AD; Sherman S; Pisarev VM; Tsiperson V; Nemachek C; Ciborowski P; Przedborski S; Mosley RL; Gendelman HE
    PLoS One; 2008 Jan; 3(1):e1376. PubMed ID: 18167537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids.
    Zarbiv Y; Simhi-Haham D; Israeli E; Elhadi SA; Grigoletto J; Sharon R
    Neurobiol Dis; 2014 Oct; 70():90-8. PubMed ID: 24905915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein.
    Mishizen-Eberz AJ; Norris EH; Giasson BI; Hodara R; Ischiropoulos H; Lee VM; Trojanowski JQ; Lynch DR
    Biochemistry; 2005 May; 44(21):7818-29. PubMed ID: 15909996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction with phospholipids modulates alpha-synuclein nitration and lipid-protein adduct formation.
    Trostchansky A; Lind S; Hodara R; Oe T; Blair IA; Ischiropoulos H; Rubbo H; Souza JM
    Biochem J; 2006 Jan; 393(Pt 1):343-9. PubMed ID: 16146428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease.
    Brembati V; Faustini G; Longhena F; Outeiro TF; Bellucci A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Ma LY; Gao LY; Li X; Ma HZ; Feng T
    Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
    Singh P; Bhat R
    ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitration in neurodegeneration: deciphering the "Hows" "nYs".
    Reynolds MR; Berry RW; Binder LI
    Biochemistry; 2007 Jun; 46(25):7325-36. PubMed ID: 17542619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.